A study by Rasanen et al. reported that elevated expression of SPINK1 is associated with poor outcomes in CRC and showed a positive correlation between SPINK1 and interleukin-6 (IL-6), indicating its role as an acute-phase reactant. The gene discussed is SPINK1; the disease is colorectal carcinoma.